Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Ashley Frazer-Abel

Concepts (337)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Complement System Proteins
17
2025
326
4.010
Why?
Complement Activation
14
2025
412
1.400
Why?
Laboratories
3
2024
109
0.970
Why?
Complement Factor B
6
2025
106
0.800
Why?
Immunoassay
2
2021
108
0.690
Why?
Macular Degeneration
4
2025
196
0.600
Why?
Clinical Laboratory Techniques
2
2018
96
0.600
Why?
Laboratories, Hospital
1
2018
14
0.560
Why?
Anti-Citrullinated Protein Antibodies
4
2026
129
0.540
Why?
Oligonucleotides, Antisense
3
2025
122
0.530
Why?
Blood Chemical Analysis
1
2018
109
0.520
Why?
RNA, Transfer
3
2008
142
0.490
Why?
Angioedemas, Hereditary
2
2014
4
0.450
Why?
Kidney Diseases
3
2025
428
0.410
Why?
RNA
3
2008
926
0.390
Why?
Antibodies, Monoclonal, Humanized
2
2023
992
0.390
Why?
Arthritis, Rheumatoid
4
2026
1185
0.370
Why?
Autoimmune Diseases
4
2022
467
0.370
Why?
Nucleic Acid Conformation
4
2008
724
0.370
Why?
Anticodon
3
2004
24
0.370
Why?
Wet Macular Degeneration
2
2025
63
0.350
Why?
Angioedema
1
2011
16
0.340
Why?
Geographic Atrophy
2
2025
105
0.330
Why?
Complement Inactivating Agents
2
2025
78
0.330
Why?
Emergency Responders
2
2021
38
0.320
Why?
Humans
56
2026
146342
0.300
Why?
Immunologic Tests
2
2021
16
0.300
Why?
Cyclin-Dependent Kinase 4
3
2006
52
0.290
Why?
Autoantibodies
3
2021
1500
0.290
Why?
T-Lymphocytes
3
2009
2012
0.280
Why?
Complement Pathway, Alternative
3
2025
123
0.280
Why?
Diabetic Retinopathy
2
2022
211
0.280
Why?
Immunoglobulins, Intravenous
2
2019
134
0.280
Why?
Specimen Handling
2
2022
178
0.280
Why?
Autoimmunity
2
2025
925
0.250
Why?
Smoking
3
2019
1486
0.250
Why?
Tars
1
2006
5
0.240
Why?
Complement Factor H
2
2019
81
0.230
Why?
Nicotine
2
2009
337
0.230
Why?
Glomerulonephritis, IGA
1
2025
14
0.230
Why?
Cyclin-Dependent Kinase 6
1
2006
49
0.230
Why?
Hydroxychloroquine
1
2026
65
0.220
Why?
Inflammation
5
2026
2919
0.220
Why?
Thionucleotides
1
2025
35
0.220
Why?
Choroid
1
2025
81
0.220
Why?
Complement C3a
3
2019
40
0.220
Why?
RNA, Transfer, Ser
2
2008
4
0.220
Why?
Cell Cycle
2
2006
595
0.210
Why?
B-Cell Activating Factor
1
2024
21
0.210
Why?
Complement Factor D
1
2024
28
0.210
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2024
78
0.200
Why?
Nuclear Proteins
3
2004
740
0.200
Why?
Complement C3
3
2025
195
0.200
Why?
Atypical Hemolytic Uremic Syndrome
1
2023
23
0.200
Why?
Scleroderma, Systemic
1
2024
124
0.200
Why?
Quality Control
2
2021
163
0.190
Why?
Biomarkers
6
2026
4340
0.190
Why?
Disease Susceptibility
4
2020
339
0.190
Why?
Vitreous Body
2
2022
118
0.190
Why?
Biosimilar Pharmaceuticals
1
2023
28
0.190
Why?
Quantitative Trait Loci
1
2025
388
0.190
Why?
Antirheumatic Agents
1
2026
309
0.190
Why?
Trichloroethylene
1
2022
8
0.180
Why?
Muscular Dystrophy, Facioscapulohumeral
1
2022
29
0.170
Why?
Protein Aggregates
2
2019
87
0.170
Why?
Neuromyelitis Optica
1
2023
135
0.170
Why?
Complement Inactivator Proteins
1
2021
39
0.170
Why?
Extracellular Traps
1
2021
54
0.170
Why?
Cross Reactions
1
2021
130
0.170
Why?
Reference Standards
1
2021
176
0.160
Why?
Europe
2
2020
421
0.160
Why?
Retinal Drusen
1
2021
31
0.160
Why?
Immunologic Factors
2
2022
244
0.160
Why?
Magnesium
4
2008
155
0.160
Why?
Health Status
1
2026
827
0.160
Why?
DNA-Binding Proteins
3
2004
1468
0.160
Why?
Sputum
1
2021
302
0.150
Why?
Transcription Factors
4
2004
1730
0.150
Why?
Alzheimer Disease
1
2026
641
0.150
Why?
Polyvinyl Chloride
1
2019
12
0.150
Why?
Diethylhexyl Phthalate
1
2019
13
0.150
Why?
Complement Membrane Attack Complex
1
2019
38
0.150
Why?
Male
23
2026
73396
0.140
Why?
Islets of Langerhans
1
2025
852
0.140
Why?
Female
24
2026
79499
0.140
Why?
Insulin-Secreting Cells
1
2023
393
0.140
Why?
Rheumatoid Factor
1
2019
177
0.140
Why?
Choroidal Neovascularization
1
2019
57
0.140
Why?
Biological Products
1
2022
258
0.140
Why?
Mass Spectrometry
1
2021
729
0.140
Why?
Occupational Exposure
1
2022
356
0.140
Why?
Mitochondria, Heart
1
1999
107
0.130
Why?
Aged
12
2026
26432
0.130
Why?
Diabetes Mellitus, Type 1
2
2025
3930
0.130
Why?
Tomography, Optical Coherence
3
2025
283
0.130
Why?
Middle Aged
14
2026
36619
0.120
Why?
Aged, 80 and over
6
2026
8391
0.120
Why?
Complement C3 Nephritic Factor
1
2016
1
0.120
Why?
Complement C5
1
2016
33
0.120
Why?
Rheumatic Diseases
1
2017
101
0.120
Why?
Riboflavin
1
2016
15
0.120
Why?
Virus Inactivation
1
2016
13
0.120
Why?
Polymorphism, Single Nucleotide
2
2025
2240
0.120
Why?
Blood
1
2016
107
0.110
Why?
Base Sequence
4
2008
2123
0.110
Why?
Glomerulosclerosis, Focal Segmental
1
2015
43
0.110
Why?
Hemorrhagic Fever, Ebola
1
2016
82
0.110
Why?
RNA, Fungal
3
2008
71
0.110
Why?
Ebolavirus
1
2016
91
0.110
Why?
Aging
1
2026
1996
0.110
Why?
Critical Illness
1
2021
908
0.110
Why?
RNA, Transfer, Phe
2
2008
9
0.110
Why?
Complement C1 Inhibitor Protein
1
2014
12
0.110
Why?
Animals
11
2022
38106
0.110
Why?
Oligoribonucleotides
1
2014
53
0.110
Why?
Disinfection
1
2016
131
0.100
Why?
Proto-Oncogene Proteins
3
2004
616
0.100
Why?
Electrophoresis, Polyacrylamide Gel
2
2008
326
0.100
Why?
Birefringence
3
2004
6
0.100
Why?
Acute Kidney Injury
1
2021
866
0.100
Why?
Adult
12
2026
41087
0.100
Why?
Double-Blind Method
3
2026
2070
0.100
Why?
Disease Progression
4
2025
2867
0.100
Why?
Diabetes Mellitus
1
2022
1101
0.100
Why?
Ultraviolet Rays
1
2016
376
0.100
Why?
Antibodies, Viral
3
2022
689
0.090
Why?
Nanoparticles
1
2019
523
0.090
Why?
Comprehension
1
2014
175
0.090
Why?
Pyrrolidinones
1
2012
29
0.090
Why?
Molecular Sequence Data
5
2014
2838
0.090
Why?
Risk Factors
5
2026
10921
0.090
Why?
Cyclin-Dependent Kinases
2
2004
121
0.090
Why?
Cattle
2
2008
940
0.090
Why?
Complement C1 Inactivator Proteins
1
2011
6
0.090
Why?
Complement C4
1
2011
31
0.090
Why?
Seroepidemiologic Studies
2
2021
171
0.080
Why?
Case-Control Studies
4
2020
3647
0.080
Why?
Inflammation Mediators
1
2012
508
0.070
Why?
Oligonucleotides
2
2014
155
0.070
Why?
Mutation
2
2020
4093
0.070
Why?
Complement C5a
2
2019
54
0.070
Why?
Drug Packaging
2
2019
41
0.070
Why?
Nicotinic Agonists
1
2009
140
0.070
Why?
Mycobacterium Infections, Nontuberculous
1
2012
339
0.070
Why?
Sequence Deletion
1
2008
190
0.070
Why?
Particle Size
2
2019
386
0.070
Why?
Phenotype
3
2022
3206
0.070
Why?
Cells, Cultured
2
2006
4118
0.060
Why?
Diagnosis, Differential
1
2011
1503
0.060
Why?
Immunoglobulin G
2
2022
901
0.060
Why?
NFATC Transcription Factors
2
2004
93
0.060
Why?
Lymphocyte Activation
2
2012
1137
0.060
Why?
Resting Phase, Cell Cycle
1
2006
16
0.060
Why?
Chemokine CXCL5
1
2026
20
0.060
Why?
Cell Survival
1
2009
1105
0.060
Why?
Chemokine CXCL9
1
2026
38
0.060
Why?
Enzyme Induction
1
2006
87
0.060
Why?
G1 Phase
1
2006
64
0.060
Why?
Kidney
2
2025
1498
0.060
Why?
Proteinuria
1
2025
103
0.060
Why?
Macaca fascicularis
2
2016
70
0.060
Why?
Phenols
1
2006
106
0.060
Why?
Temperature
1
2008
635
0.060
Why?
Enzyme-Linked Immunosorbent Assay
2
2019
846
0.050
Why?
Chromosome Mapping
1
2025
508
0.050
Why?
Peptides, Cyclic
1
2026
276
0.050
Why?
Hemangiosarcoma
1
2004
27
0.050
Why?
RNA Processing, Post-Transcriptional
1
2004
92
0.050
Why?
Young Adult
4
2025
14330
0.050
Why?
Plasmids
1
2004
373
0.050
Why?
Follow-Up Studies
2
2025
5439
0.050
Why?
Amyloid beta-Peptides
1
2026
251
0.050
Why?
Rare Diseases
1
2023
117
0.050
Why?
Interferon-gamma
1
2026
781
0.050
Why?
Complement Factor I
1
2022
12
0.050
Why?
Dog Diseases
1
2004
140
0.050
Why?
Neovascularization, Pathologic
1
2004
287
0.050
Why?
Cross-Sectional Studies
2
2025
5899
0.040
Why?
Antibodies, Antinuclear
1
2022
60
0.040
Why?
Aqueous Humor
1
2022
41
0.040
Why?
Glomerular Filtration Rate
1
2025
745
0.040
Why?
Interleukin-6
1
2026
784
0.040
Why?
Time Factors
2
2025
7109
0.040
Why?
World Health Organization
1
2022
104
0.040
Why?
Cytokines
2
2012
2081
0.040
Why?
Albumins
1
2022
120
0.040
Why?
Adolescent
5
2025
22557
0.040
Why?
Gene Expression Regulation
2
2002
2599
0.040
Why?
Fibrinogen
1
2022
182
0.040
Why?
Apoptosis
1
2009
2439
0.040
Why?
Microspheres
1
2021
142
0.040
Why?
Pancreas
1
2023
343
0.040
Why?
Spike Glycoprotein, Coronavirus
1
2022
129
0.040
Why?
Colorado
2
2021
4595
0.040
Why?
Vascular Endothelial Growth Factor A
2
2019
545
0.040
Why?
United States
1
2018
16136
0.040
Why?
Cardiac Catheterization
1
2024
571
0.040
Why?
Immunoglobulin M
1
2022
284
0.040
Why?
RNA, Messenger
3
2004
2791
0.040
Why?
RNA, Bacterial
1
2001
183
0.040
Why?
Predictive Value of Tests
1
2025
2113
0.040
Why?
Vitrectomy
1
2020
74
0.040
Why?
Child
4
2025
22693
0.040
Why?
Complement C4a
1
2019
9
0.040
Why?
Freezing
1
2019
83
0.040
Why?
Plasticizers
1
2019
18
0.040
Why?
Syringes
1
2019
53
0.040
Why?
Gas Chromatography-Mass Spectrometry
1
2019
124
0.040
Why?
Drug Contamination
1
2019
56
0.040
Why?
South Carolina
1
2019
46
0.040
Why?
Cations, Divalent
1
1999
46
0.040
Why?
Drug Compounding
1
2019
106
0.040
Why?
Rheology
1
2019
94
0.040
Why?
Drug Stability
1
2019
172
0.040
Why?
Yeasts
1
1999
54
0.040
Why?
Protein Stability
1
2019
180
0.030
Why?
Cell Proliferation
1
2006
2502
0.030
Why?
Surface Properties
1
2019
384
0.030
Why?
Calcium
1
2004
1181
0.030
Why?
Fluorescein Angiography
1
2019
197
0.030
Why?
Pituitary Gland, Anterior
1
1997
37
0.030
Why?
Complement Pathway, Classical
1
2017
18
0.030
Why?
Thrombotic Microangiopathies
1
2017
19
0.030
Why?
Prolactin
1
1997
88
0.030
Why?
Complement Pathway, Mannose-Binding Lectin
1
2017
23
0.030
Why?
Body Mass Index
2
2019
2458
0.030
Why?
Fibroblast Growth Factor 2
1
1997
93
0.030
Why?
Stress, Mechanical
1
2019
497
0.030
Why?
Anti-Inflammatory Agents
1
2021
474
0.030
Why?
Promoter Regions, Genetic
2
2002
1242
0.030
Why?
Mice
3
2022
18297
0.030
Why?
Biomarkers, Tumor
1
2024
1339
0.030
Why?
Epitopes
1
2019
479
0.030
Why?
Escherichia coli
1
2001
832
0.030
Why?
Genetic Testing
1
2020
492
0.030
Why?
HIV Infections
1
2012
3215
0.030
Why?
Jurkat Cells
2
2009
115
0.030
Why?
Genetic Predisposition to Disease
1
2025
2488
0.030
Why?
Odds Ratio
1
2019
1077
0.030
Why?
Motivation
1
2021
605
0.030
Why?
Fibroblast Growth Factors
1
1997
187
0.030
Why?
Severity of Illness Index
1
2024
2921
0.030
Why?
Disease Management
1
2020
651
0.030
Why?
Vero Cells
1
2016
84
0.030
Why?
Complement C5b
1
2015
5
0.030
Why?
Child, Preschool
2
2025
11913
0.030
Why?
Societies, Medical
1
2020
907
0.030
Why?
Intensive Care Units
1
2021
925
0.030
Why?
Lupus Erythematosus, Systemic
1
2017
241
0.030
Why?
Patient Education as Topic
1
2020
770
0.030
Why?
Molecular Targeted Therapy
1
2017
447
0.030
Why?
Amino Acid Sequence
2
2014
2092
0.030
Why?
Longitudinal Studies
1
2022
3017
0.030
Why?
Quality Assurance, Health Care
1
2016
349
0.030
Why?
Retrospective Studies
2
2025
17438
0.030
Why?
Gene Expression
1
2019
1463
0.030
Why?
Logistic Models
1
2019
2126
0.020
Why?
RNA Polymerase II
1
1997
347
0.020
Why?
Signal Transduction
3
2009
5246
0.020
Why?
Binding Sites
3
2002
1309
0.020
Why?
Saccharomyces cerevisiae Proteins
1
1997
411
0.020
Why?
Hypertension, Pulmonary
1
2024
1957
0.020
Why?
gag Gene Products, Human Immunodeficiency Virus
1
2012
10
0.020
Why?
CD4-CD8 Ratio
1
2012
23
0.020
Why?
Clinical Decision-Making
1
2016
365
0.020
Why?
nef Gene Products, Human Immunodeficiency Virus
1
2012
19
0.020
Why?
Raltegravir Potassium
1
2012
18
0.020
Why?
Chemokine CCL5
1
2012
40
0.020
Why?
Funnel Chest
1
2012
31
0.020
Why?
Adipokines
1
2012
56
0.020
Why?
Insulin
1
2023
2525
0.020
Why?
Cell Division
2
2004
736
0.020
Why?
Practice Guidelines as Topic
1
2020
1591
0.020
Why?
Muscle, Skeletal
1
2022
1818
0.020
Why?
Age Factors
1
2019
3347
0.020
Why?
Antiretroviral Therapy, Highly Active
1
2012
278
0.020
Why?
Treatment Outcome
1
2025
11821
0.020
Why?
Dose-Response Relationship, Drug
1
2014
2022
0.020
Why?
Viral Load
1
2012
526
0.020
Why?
Immunologic Memory
1
2012
369
0.020
Why?
Leukemia, T-Cell
1
2009
5
0.020
Why?
Scoliosis
1
2012
231
0.020
Why?
Prospective Studies
1
2021
8123
0.020
Why?
Algorithms
1
2016
1849
0.020
Why?
Adipose Tissue
1
2012
642
0.020
Why?
Transfection
2
2002
916
0.020
Why?
Receptors, Nicotinic
1
2009
337
0.020
Why?
Pilot Projects
1
2012
1888
0.020
Why?
HIV-1
1
2012
913
0.010
Why?
CD8-Positive T-Lymphocytes
1
2012
931
0.010
Why?
CD4-Positive T-Lymphocytes
1
2012
1150
0.010
Why?
Ploidies
1
2004
21
0.010
Why?
DNA, Neoplasm
1
2004
160
0.010
Why?
Protein Binding
2
2001
2244
0.010
Why?
Precipitin Tests
1
2002
90
0.010
Why?
Cell Adhesion
1
2004
447
0.010
Why?
Dogs
1
2004
517
0.010
Why?
Luciferases
1
2002
153
0.010
Why?
Genes, Reporter
1
2002
275
0.010
Why?
Cloning, Molecular
1
2002
526
0.010
Why?
Cyclosporine
1
2002
256
0.010
Why?
Tacrolimus
1
2002
192
0.010
Why?
Exons
1
2002
361
0.010
Why?
Base Pairing
1
2001
65
0.010
Why?
Histone Deacetylases
1
2002
208
0.010
Why?
Antigens, CD
1
2004
560
0.010
Why?
Lymphocytes
1
2002
379
0.010
Why?
Transcriptional Activation
1
2002
369
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2002
974
0.010
Why?
RNA Stability
1
2001
119
0.010
Why?
Models, Genetic
1
2002
540
0.010
Why?
Ribosomes
1
2001
196
0.010
Why?
Cell Movement
1
2004
951
0.010
Why?
Chromatin
1
2002
559
0.010
Why?
Phosphorylation
1
2002
1724
0.010
Why?
Transcription Factor Pit-1
1
1997
26
0.010
Why?
Fibroblast Growth Factor 4
1
1997
19
0.010
Why?
Proto-Oncogene Proteins c-raf
1
1997
46
0.010
Why?
Proto-Oncogene Protein c-ets-1
1
1997
26
0.010
Why?
Proto-Oncogene Proteins c-ets
1
1997
54
0.010
Why?
Endothelium, Vascular
1
2004
952
0.010
Why?
Mice, Transgenic
1
2002
2134
0.010
Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
1997
165
0.010
Why?
Genes, Fungal
1
1997
55
0.010
Why?
Coenzymes
1
1997
23
0.010
Why?
Catalysis
1
1997
304
0.010
Why?
Models, Biological
1
2004
1761
0.010
Why?
Proto-Oncogene Proteins p21(ras)
1
1997
250
0.010
Why?
Gene Expression Regulation, Fungal
1
1997
79
0.010
Why?
Fungal Proteins
1
1997
137
0.010
Why?
Mediator Complex
1
1997
61
0.010
Why?
Cell Line, Tumor
1
2004
3545
0.010
Why?
Models, Molecular
1
2001
1573
0.010
Why?
Tumor Cells, Cultured
1
1997
882
0.010
Why?
Protein-Tyrosine Kinases
1
1997
429
0.010
Why?
Homeodomain Proteins
1
1997
525
0.010
Why?
Rats
1
1997
5586
0.000
Why?
Frazer-Abel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)